Managing Bipolar Without Medication: Guidelines and Trials

Bipolar treatment guidelines from NICE (updated September 2025) and CANMAT/ISBD (2018) make medication the basis of long-term care, and Brightside and Talkiatry say the same on their own bipolar pages.¹²

Added to medication, structured therapy lowered the odds of a new episode in a 39-trial analysis (odds ratio 0.56), and family-focused therapy cut two-year relapse from 54% to 35% in one trial.³⁴

Across 22 trials, people who stayed on maintenance medication were about 39% less likely to have a new mood episode within six months than people who stopped.⁵

If you’re wondering whether you can manage bipolar disorder without medication, you may be worried about side effects, cost, or what long-term treatment will mean for you. Those concerns deserve a conversation. I’d start by asking what you want to change about your treatment, so you and your prescriber can discuss options that address it.

Bipolar disorder involves episodes of mania or hypomania and depression. NIMH says it usually needs lifelong treatment, and mood stabilizers and some antipsychotics can help prevent episodes. Therapy can lower relapse risk when added to medication. Regular sleep and limiting alcohol and drugs are also part of guideline recommendations. The only trial we found that tested therapy without mood medication involved people with bipolar II depression. Below, we’ll look at what that study found and how it compares with the broader evidence.

If you’re considering online care, Brightside Health offers psychiatrists and therapists by video. It treats bipolar I and II when there’s no acute mania. To see whether your insurance covers psychiatry and therapy together, run Brightside’s free eligibility check.

This article is for information only and is not medical advice. Talk to a doctor or licensed clinician before starting, stopping, or changing any treatment.

If signs of mania, psychosis or thoughts of suicide come up, call or text 988, the free Suicide and Crisis Lifeline, or call 911 in an emergency.

ChoosingTherapy.com may earn a commission from the companies whose services are linked on this page.

Can bipolar disorder be managed without medication?

No major guideline recommends managing bipolar disorder without medication, and none recommends replacing medication with therapy for bipolar I. CANMAT/ISBD, the Canadian and international guideline, describes medication as essential and the foundation of treatment. Therapy may help with depression and relapse prevention when added to medication. No psychological treatment has evidence supporting its use during acute mania.¹ The guideline’s 2021 update on mixed episodes added no recommendation for therapy alone.

NICE, the UK guideline body, calls lithium the most effective long-term treatment.² It also recommends a structured psychological treatment designed for bipolar disorder, using a treatment manual, to help prevent relapse. The American Psychiatric Association’s bipolar guideline dates from 2002. It is now listed among the organization’s legacy guidelines, with no newer version. Brightside describes medication as typically essential, while Talkiatry says bipolar disorder is almost always managed with medication.

A trial of therapy without mood medication

One 2018 trial studied 92 unmedicated adults with bipolar II depression.⁶ Everyone received weekly interpersonal and social rhythm therapy (IPSRT) for 20 weeks, along with either quetiapine or a placebo. About 67% responded overall, but those taking quetiapine improved faster.

The study had no group that received no therapy, so it can’t tell us how much improvement came from IPSRT itself. A 2025 reanalysis found that suicidal thoughts decreased in both groups during therapy. Its authors suggested IPSRT alone may suit some people with bipolar II who can’t take medication or prefer to avoid it. No one in the trial had bipolar I, which limits who these findings apply to.

What therapy adds to bipolar medication

Structured therapy can lower relapse risk when added to medication. A 2021 network meta-analysis of 39 trials included 3,863 people, all taking medication. It found that these therapies lowered the odds of a new episode (odds ratio 0.56).³ Family or group psychoeducation that included skills practice worked better than the same content delivered one to one.

CANMAT/ISBD rates psychoeducation as a first-line option for staying well. CBT and family-focused therapy are second-line options; IPSRT and peer support are third-line options.¹ Our guide to treatments for bipolar disorder explains how each fits with medication.

Psychoeducation and family-focused therapy

Group psychoeducation helps you understand bipolar disorder, recognize early warning signs, and maintain routines. In a trial of 120 people in remission, participants attended 21 group sessions. Over five years, they had fewer recurrences than those attending unstructured meetings (3.86 vs 8.37) and spent fewer days acutely ill (154 vs 586).⁷

Family-focused therapy includes a partner or relatives and teaches communication and problem-solving skills. A trial followed 101 people after a mood episode. Over two years, 35% of those receiving family-focused therapy relapsed, compared with 54% of those receiving crisis management.⁴ The family-therapy group also took medication more consistently.

CBT and IPSRT

The findings for CBT are mixed. A trial of 103 people with bipolar I found fewer episodes and hospital admissions over a year. A larger trial of 253 people found no difference in relapse. Our article on CBT for bipolar disorder explains the techniques.

IPSRT focuses on relationships and keeping sleep, meals, and activity at consistent times. In a trial of 175 people with bipolar I, those receiving IPSRT went longer before having a new episode. More consistent daily rhythms were also associated with fewer recurrences.

As of October 2026, from the studies cited. Participants in the therapy and light trials were on medication.

Sleep, daily routine and substance use

Sleep loss can trigger mania. A survey of 3,140 people with bipolar disorder asked whether losing sleep had triggered a high. People with bipolar I had nearly three times the odds of reporting this compared with people with bipolar II (odds ratio 2.81). Women had higher odds than men.⁸ In a pilot trial of 58 people with bipolar I and insomnia, 8 sessions of bipolar-adapted CBT for insomnia reduced relapse into hypomania or mania to 4.6%, compared with 31.6% with psychoeducation.

NIMH recommends regular times for eating, sleeping, and exercise, along with a mood journal or life chart to help catch mood changes early. CANMAT/ISBD also recommends limiting alcohol, tobacco, drugs, and caffeine.¹ About 42% of people with bipolar disorder in clinical samples have had an alcohol use disorder, and 20% have had a cannabis use disorder. A review of prospective studies linked cannabis to worse manic symptoms, although the authors described that finding as tentative.

Exercise, supplements and other approaches with weaker evidence

Exercise, supplements, and light therapy have weaker evidence than the therapies discussed above. Some can also increase the risk of mania.

Exercise reduced depressive and anxiety symptoms in a 2025 meta-analysis of 7 trials involving 576 adults. It had no effect on mania, and the evidence was low quality.⁹ A 2026 analysis of three smaller bipolar trials found no effect on depression. An earlier review found some evidence linking vigorous exercise with mania.

A 2012 meta-analysis found that omega-3 added to medication had a small effect on bipolar depression and no effect on mania.¹⁰ NIMH notes that the FDA hasn’t approved any complementary approach for bipolar disorder. NCCIH warns that SAMe may worsen mania.

In a 2018 trial, 46 people with bipolar depression who were taking mood-stabilizing medication received bright light at midday or a dim placebo light. Remission occurred in 68.2% of the bright-light group, compared with 22.2% of the placebo group, with no switches into mania.¹¹ In an earlier case series, three of four women receiving morning light developed mixed states. CANMAT/ISBD lists light therapy as a third-line addition to medication for bipolar I depression.¹

Research on the ketogenic diet in bipolar disorder is limited to small studies. In a four-month Stanford pilot, 23 people with bipolar disorder or schizophrenia continued their medication. By the end, none met the criteria for metabolic syndrome, and overall symptom severity fell by 31%.¹² A 6- to 8-week Edinburgh pilot involving 27 people found weight loss but no significant mood change.¹³ Neither study had a control group. The one randomized trial that included bipolar disorder lasted a month and also enrolled people with schizophrenia.¹⁴ No guideline recommends the diet. If you take lithium or valproate, ask your prescriber before starting it. Researchers advise checking blood levels of both drugs.

Bipolar relapse plans and peer support

A relapse plan gives you and your care team agreed steps to follow when warning signs appear. In a 1999 trial of 69 people, learning to recognize early signs and get prompt treatment led to 30% fewer manic relapses over 18 months.

NICE recommends making a plan with your care team that lists triggers, early warning signs, coping steps, any extra medication agreed in advance, and who to contact in a crisis.² In a UK trial, joint crisis plans reduced compulsory admission or treatment from 27% to 13% over 15 months. If warning signs of mania or suicidal thoughts appear, contact your care team, or call or text 988 for immediate support.

The Depression and Bipolar Support Alliance (DBSA) offers peer-led support groups in person and online, with more than 20,000 meetings a year. DBSA explains that these meetings are not group therapy.

If you want to take fewer bipolar medications

In user forums, side effects are the most common reason people give for wanting to cut back on medication. NIMH advises against stopping without your provider. NAMI gives the same advice when cost is the concern.

I’d bring the specific concern to your appointment: the side effect that’s bothering you, the cost you can’t sustain, or the blood tests you find difficult. That gives your prescriber a clearer starting point for discussing your options.

This article is for information only and is not medical advice. Talk to a doctor or licensed clinician before starting, stopping, or changing any treatment.

What the data show after stopping

In a pooled analysis of 257 people with bipolar I, more than half of new episodes occurred within 10 weeks of stopping lithium.¹⁵ A 22-trial meta-analysis found that stopping maintenance medication increased recurrence within six months across lithium, lamotrigine, quetiapine, and other drugs. Still, 47.3% of those who stopped stayed well for six months.⁵ A 2013 review of 48 trials in mood disorders also found fewer suicide deaths with lithium than with placebo.

Talking with your prescriber

NICE recommends discussing the benefits and risks of each long-term medication, including the risks of stopping. This includes conversations with women who may want to become pregnant.² If you and your prescriber agree to stop lithium, NICE recommends reducing it over at least 4 weeks, preferably up to 3 months, with close monitoring for 3 months afterward.

Lithium requires regular blood tests. NICE lists not wanting those tests as a reason to consider another medication. Our guide to medications for bipolar disorder includes questions to ask your prescriber.

How Brightside treats bipolar disorder

Brightside’s bipolar care includes medication management, therapy, mood tracking, and lifestyle support. Its psychiatrists work with mood stabilizers and atypical antipsychotics, while its therapists use CBT and IPSRT. Providers help determine whether and when to taper medication.

Brightside’s published medication list includes aripiprazole, lamotrigine, divalproex, and quetiapine. Lithium isn’t listed. If you take lithium, ask before signing up whether Brightside can continue your prescription and arrange blood tests.

The psychoeducation and family-focused therapy trials discussed above each involved 21 sessions. Brightside lists CBT and IPSRT but doesn’t say it offers a structured group psychoeducation or family-focused therapy program.

How to start

Brightside’s bipolar page outlines four steps:

Check your insurance with a free eligibility check.

Answer a short assessment.

Choose a provider and book a first appointment.

Start treatment and track your progress.

The first psychiatry visit is usually a 30-minute video appointment. Follow-ups occur every few months, or sooner when treatment changes.

What it costs

Unlike its ADHD care, Brightside’s pricing pages don’t limit bipolar care to insured members. Its self-pay plans apply: $95 a month for psychiatry plus pharmacy copays, $299 for four therapy sessions plus messaging, or $349 for both.

With insurance, the average copay is $25. Brightside says more than half of insured members have a $0 copay. It confirmed to us in September 2026 that it accepts Aetna, Cigna, UnitedHealthcare and Oscar, Original Medicare Part B, and named Medicaid plans in five states. It does not accept Kaiser or Humana.

For comparison, Talkiatry’s 2024 cost guide estimates that a psychiatrist charges self-pay patients up to $300 to $500 for a first evaluation and $100 to $300 for each follow-up. See what Brightside costs on your plan.

What users report about Brightside and Talkiatry

On October 12, 2026, Brightside had a Trustpilot score of 4.0 from 1,564 reviews. Six reviews mentioned bipolar disorder. Two praised feeling heard, while two said check-ins focused on depression and anxiety. The scales Brightside names are the PHQ-9 and GAD-7. Two one-star reviews from 2023 described intake problems: the quiz didn’t list bipolar disorder, and one reviewer was turned away because of a hospitalization more than 25 years earlier.

Talkiatry had a Trustpilot score of 2.6 from 1,046 reviews and an F rating from the BBB. Reviewers frequently reported unexpected charges. All four reviews mentioning bipolar disorder gave one or two stars, citing costs and being declined because their needs were considered too complex.

When Brightside isn’t the right fit for bipolar care

Brightside says online care isn’t suitable for some cases of bipolar I, acute mania, any symptoms of psychosis, or ongoing high-risk self-harm. It recommends in-person care for people in those situations. During mania or a crisis, call or text 988, or call 911 if you are in immediate danger.

If Brightside’s screening finds that your bipolar I isn’t a fit for its online care, Talkiatry is another option. Its psychiatrists specialize in mood disorders and can prescribe mood stabilizers and antipsychotics by video. At the first visit, your psychiatrist checks whether virtual care is suitable and may recommend in-person or hybrid care for severe episodes.

Talkiatry is in network with more than 200 insurance plans, and most patients pay $30 a visit. It accepts Original Medicare Part B but not Medicaid. Medicaid members can check Brightside’s named plans instead.

For bipolar I or II without acute mania, start Brightside’s free assessment to be matched with a psychiatrist and therapist.